PETALING JAYA: Malaysia will decide on the use of the AstraZeneca vaccine for Covid-19 following a report by the European Medicines Agency (EMA) of rare blood clots being a possible side-effect, says Khairy Jamaluddin.
The Science, Technology and Innovation Minister said the Special Committee on Covid-19 Vaccine Supply Access Guarantee (JKJAVMY) will take the announcement into consideration to decide if Malaysia will administer the AstraZeneca vaccine to its citizens as planned.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
